Operates as a high-volume manufacturer that converts raw materials into disposable protective and rehabilitation products, earning through unit sales at industrial scale into healthcare, industrial and food-service markets.
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $5.06B, above the global median of $1.18B
- PositionCurrent ratio is 0.98×, lower than 95% of its Medical Instruments & Supplies peers (median 2.67×)
- Interpretations1 currently firing — 1
What this company is and how it runs — written from structure, not news.
CompanyGraph's reading of its position in the wider economy places it toward the upstream end of its supply chain: it draws the materials it converts from a narrow band of input industry, then distributes standardized output across a considerably broader set of downstream industries. That arrangement is consistent with a production system whose core job is converting and moving material at volume, rather than one that mainly connects buyers and sellers or manages risk on their behalf.
Its financial record shows revenue, gross profit and net income all moving upward together across consecutive reported years, with net income positive throughout, growth and profitability arriving together rather than one improving at the expense of another. CompanyGraph reads this as consistent with a business that earns by running high volumes of standardized, largely single-use product through its plants, so income tracks volume moved rather than pricing power on any one item.
This way of converting purchased material into standardized output through fixed plant is shared by a very large population of other companies elsewhere in the economy, making it common rather than rare. Within that pattern, CompanyGraph reads scale as growing mainly by adding physical production capacity or running existing capacity more fully rather than by expanding without added plant, and the company's own materials describe manufacturing capacity spread across several named production sites.
CompanyGraph's mapped supply position shows the company sourcing the inputs it converts from a narrow band of upstream industry rather than a wide spread of input sources; this describes its place in the wider economy rather than naming specific suppliers. Its own published materials do not identify specific suppliers, single-source inputs, or raw-material concentration.
The same mapped position shows the company's output reaching a considerably broader set of downstream industries than the narrow band it draws inputs from, consistent with a maker of standardized products used across many kinds of end use rather than one serving a single narrow buyer category. Its own published materials do not name customers or disclose customer concentration.
The underlying way this company converts material into standardized product at volume is common to a very large number of other companies, so that way of operating is not distinctive on its own. Its own account positions it by scale within one product category, describing itself as the world's largest manufacturer of non-latex gloves; CompanyGraph has no evidence on whether competitors could replicate that scale and makes no claim either way.
The company's own account states a fixed annual manufacturing capacity across its glove and wheelchair production, a ceiling on how many units its plants can produce in a year rather than an open-ended figure. That fits the wider pattern CompanyGraph treats as a starting hypothesis for this kind of production system, that output is bound by how much physical plant exists and how fully it runs, though CompanyGraph cannot independently verify current utilization against that stated ceiling.
The company's own materials describe operating under several named medical-device and protective-equipment regulatory regimes across different jurisdictions, including market-clearance and quality-management requirements in the United States and Europe. Continued access to those markets rests on maintaining the relevant clearances and certifications, a condition set externally by regulators rather than by the company's own manufacturing choices.
Read from the company's own filings and public materials (gathered August 2026) together with figures CompanyGraph recomputed from its statements. Written September 2026. A question with no evidence behind it is left out rather than answered.
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
The reported statements, read against the company's own industry.
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Financial Health
Supply Chain
Scale
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.